Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115635
Status:
COMPLETED
Last Update Posted:
2007-10-02
First Post:
2005-06-23
Brief Title:
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer
Sponsor:
Herlev Hospital
Organization:
Herlev Hospital
Organization Data
Organization:
Herlev Hospital
Class:
OTHER
Study ID:
UR0416
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herlev Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
| Sanofi | INDUSTRY |